Roche drug that previously failed in Covid-19 pneumonia shows efficacy in Phase III study
An autoimmune drug that failed in a previous clinical trial to improve conditions for patients with severe Covid-19 has shown efficacy in a second study....
Tag : Roche
Regeneron, Roche team up in global deal on Covid-19 antibody cocktail
A major European pharmaceutical company has signed on to distribute an antibody drug under development for Covid-19 outside the U.S. Tarrytown, New York-based Regeneron Pharmaceuticals...
FDA approves Roche drug for rare autoimmune disorder NMOSD
The Food and Drug Administration has approved a drug for treating a rare autoimmune disorder that can cause blindness, muscle weakness and paralysis. Basel, Switzerland-based...
FDA approves Roche, PTC drug for spinal muscular atrophy
The Food and Drug Administration has approved the latest entrant into the market for drugs to treat spinal muscular atrophy. South Plainfield, New Jersey-based PTC...
Phase III study of Roche anti-inflammatory drug in Covid-19 fails
Results of a trial of an anti-inflammatory drug from Swiss pharmaceutical giant Roche in patients with Covid-19 have shown the drug to be ineffective, the...
Roche, PicnicHealth start RWD partnership with multiple sclerosis focus
Swiss drugmaker Roche and its U.S. subsidiary are working with a startup focused on real-world data to use patient data to advance research in multiple...
Roche pays Blueprint $675M upfront for ex-U.S. development, commercialization rights to cancer drug
Swiss drugmaker Roche has signed an agreement potentially worth more than $1.7 billion focused on an investigational drug designed to treat cancers by targeting genetic...